巨星医疗控股(02393.HK)可能收购一间非全资附属公司所有余下权益
格隆汇 8 月 3日丨巨星医疗控股(02393.HK)发布公告,公司现正考虑并商讨收购公司其中一间非全资附属公司所有余下权益的可行性。
公告表示,考虑到近期中国医疗保健行业不景气,公司有意进一步扩大及巩固于中国的市场占有率。于该公布日期,公司未有订立任何具法律约束力的具体协议或合约。可能收购事项有待订约各方进一步磋商,未必一定落实。可能收购事项一经落实,预期会构成上市规则第十四章下公司的须予公布交易。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.